These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28328105)

  • 1. Osteonecrosis of the Jaw in a Breast Cancer Patient Treated with Everolimus and a Single Dose of Zoledronic Acid.
    Omarini C; Filieri ME; Depenni R; Grizzi G; Cascinu S; Piacentini F
    Breast J; 2017 Sep; 23(5):610-611. PubMed ID: 28328105
    [No Abstract]   [Full Text] [Related]  

  • 2. Bisphosphonate-related osteonecrosis of the jaw and left thumb.
    Longo R; Castellana MA; Gasparini G
    J Clin Oncol; 2009 Dec; 27(35):e242-3. PubMed ID: 19858386
    [No Abstract]   [Full Text] [Related]  

  • 3. Medical image. Osteolytic jaw lesion in metastatic breast cancer: not always metastases. Osteonecrosis of the jaw.
    Alvarez-Busto I; Martinez-Moya L; Lastra R; Alcedo J; Quiles D; Lobo-Escolar A; Vazquez C; Burillo M; Toyas-Miazza C; Ortas-Nadal R
    N Z Med J; 2007 Sep; 120(1262):U2726. PubMed ID: 17891214
    [No Abstract]   [Full Text] [Related]  

  • 4. Bisphosphonate-related osteonecrosis of the jaws an old disease with a new drug?
    Carlson ER
    Cranio; 2010 Jan; 28(1):1-2. PubMed ID: 20158003
    [No Abstract]   [Full Text] [Related]  

  • 5. Bisphosphonate osteonecrosis of the jaws in cancer patients.
    Kyrgidis A; Andreadis C
    Breast; 2009 Oct; 18(5):335. PubMed ID: 19783147
    [No Abstract]   [Full Text] [Related]  

  • 6. The phenomenon of osteonecrosis of the jaw in patients with metastatic breast cancer.
    Van Poznak C
    Cancer Invest; 2006 Feb; 24(1):110-2. PubMed ID: 16467002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients.
    Wutzl A; Eisenmenger G; Hoffmann M; Czerny C; Moser D; Pietschmann P; Ewers R; Baumann A
    Wien Klin Wochenschr; 2006 Aug; 118(15-16):473-8. PubMed ID: 16957978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetracycline-guided debridement and cone beam computed tomography for the treatment of bisphosphonate-related osteonecrosis of the jaw: a technical note.
    Fleisher KE; Doty S; Kottal S; Phelan J; Norman RG; Glickman RS
    J Oral Maxillofac Surg; 2008 Dec; 66(12):2646-53. PubMed ID: 19022151
    [No Abstract]   [Full Text] [Related]  

  • 9. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.
    Ruggiero SL; Fantasia J; Carlson E
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):433-41. PubMed ID: 16997108
    [No Abstract]   [Full Text] [Related]  

  • 10. Why osteonecrosis of the jaw after bisphosphonates treatment is more frequent in multiple myeloma than in solid tumors.
    Delibasi T; Altundag K; Kanlioglu Y
    J Oral Maxillofac Surg; 2006 Jun; 64(6):995-6. PubMed ID: 16713825
    [No Abstract]   [Full Text] [Related]  

  • 11. Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancer.
    Sanna G; Preda L; Bruschini R; Cossu Rocca M; Ferretti S; Adamoli L; Verri E; Franceschelli L; Goldhirsch A; Nolè F
    Ann Oncol; 2006 Oct; 17(10):1512-6. PubMed ID: 16936182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update.
    Ruggiero SL; Dodson TB; Assael LA; Landesberg R; Marx RE; Mehrotra B;
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):2-12. PubMed ID: 19371809
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diphosphonates can cause necrosis of the jaw. Patients with malignant skeletal diseases are at risk].
    Jarnbring F; Ulmner M; Blomlöf J; Ljungman P
    Lakartidningen; 2006 May 31-Jun 6; 103(21-22):1741-3. PubMed ID: 16826719
    [No Abstract]   [Full Text] [Related]  

  • 14. [A case of bisphosphonate-associated osteonecrosis of the jaw in a patient with bone metastasis of breast cancer].
    Iimura Y; Kaneko H; Hasegawa N; Takahashi Y; Shoji Y; Kawabata M
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1791-3. PubMed ID: 20841949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral osteonecrosis associated with the use of zoledronic acid: first case of a patient with advanced pancreatic cancer and bone metastases.
    Smith A; Kressley A; Saif MW
    JOP; 2009 Mar; 10(2):212-4. PubMed ID: 19287122
    [No Abstract]   [Full Text] [Related]  

  • 16. Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?
    Ardine M; Generali D; Donadio M; Bonardi S; Scoletta M; Vandone AM; Mozzati M; Bertetto O; Bottini A; Dogliotti L; Berruti A
    Ann Oncol; 2006 Aug; 17(8):1336-7. PubMed ID: 16524968
    [No Abstract]   [Full Text] [Related]  

  • 17. Osteonecrosis of the Torus Palatinus in the Setting of Long-Term Oral Bisphosphonate Use--A Case Report.
    Ryan JL; Larson E
    S D Med; 2016 Jan; 69(1):23-5. PubMed ID: 26882578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate-related osteonecrosis of the jaw around dental implants in the maxilla: report of a case.
    Shirota T; Nakamura A; Matsui Y; Hatori M; Nakamura M; Shintani S
    Clin Oral Implants Res; 2009 Dec; 20(12):1402-8. PubMed ID: 19793318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is exposure of the jawbone mandatory for establishing the diagnosis of bisphosphonate-related osteonecrosis of the jaw?
    Yarom N; Fedele S; Lazarovici TS; Elad S
    J Oral Maxillofac Surg; 2010 Mar; 68(3):705. PubMed ID: 20171493
    [No Abstract]   [Full Text] [Related]  

  • 20. Osteonecrosis of the jaw & osteoporosis therapy.
    Kessenich CR
    Nurse Pract; 2010 Jul; 35(7):51-3. PubMed ID: 20555246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.